What is really driving DiaMedica DMAC stock price movement DiaMedica posts 74 EPS beat narrower than expected loss Goldman Sachs Group Inc GS Alternatives Division Leads 60M Series C Funding for Workplace Fintech Kashable Expanding Inclusive Growth Investment Portfolio TEL TE reports slight Q1 2026 EPS outperformance stock rises modestly in todays trading Gilead Sciences GILD Q1 2026 Earnings Analysis Revenue Beats Forecast Amid Mixed Product Performance Ionis Pharmaceuticals Q1 2026 Earnings EPS Beat Driven by Cost Discipline Stock Holds Steady Hyperfine Inc HYPR Q1 2026 Earnings EPS Surprises to the Upside Stock Jumps 11 NVAX Q1 2026 Earnings NarrowerThanExpected Loss Beats Estimates Stock Edges Higher TXMD Q3 2023 Earnings EPS Misses Estimates by Wide Margin Amidst Operational Challenges Huntington Bancshares HBANZ Q1 2026 Earnings Preferred Stock EPS Falls Short of Estimates Amid Narrowing Net Interest Margin RDHL Q2 2022 Earnings Massive EPS Miss Despite No Revenue Stock Rises 481